Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Liquidmetal 10Q
https://liquidmetal.gcs-web.com/node/12026/html
At this point, any new account will move the needle up.
Would you happen to know the minimum order amount that Yihao Metal Technology will accept? I thought it was well above the estimated 5300 Evie rings sold. Thanks in advance.
Well MOVANO was a bit disappointing in their earnings release….slightly more than 5k.units shipped in Q1…. If they double each quarter they get all the way to 80k for the year it amounts to $20 million in revenue for them but probably something like $200k for LQMT. That will hardly move the needle.
Looks like we will need at least 10 of these to have real impact.
WattsWatt, thanks. I look for your input into the future for our amorphous metal alloys with great interest and anticipation. Would be quite something should a future amorphous metal alloy be used for the reactor core and with the combination of liquid metal to prevent neutron leakage. Who knows what changes we will see.
It's exciting to think of the possibilities especially as AI gets cranking. I know one thing for certain. I will certainly being buying the dips.
Monroe, you, in particular, continue to fail to realize the difference between our bulk metallic glasses and other substances like the lithium bath mentioned hear for nuclear reactors and gallium type metals used as heat sinks for computer cpu's. When are you ever going to understand what our product is and what it is not. Try doing some research and thinking before shooting arrows into the sky and not where they land knowing not where. You seem oblivious to rudimentary facts.
The day cannot come soon enough for transparency to become normal in LQMT.
Not only would I be happy with $1. I would settle for 50 cents...
okpj
Yes, it would have been nice! The sheer number of future applications as the sciences are developed makes me want to always hold on to some of these shares.
No telling what AI is going to say about liquid metal/amorphous. The whole world is in transition due to rapid technology improvements and discoveries. At some point the company is bound to hit upon a big winner. The day cannot come soon enough for transparency to become normal in LQMT.
It would be nice to be a critical part of the fusion power development but this is a completely different application.
Liquid Metal vs LiquidMetal ….a world of difference.
No telling what the future will reveal as to amorphous metals.
https://focusfusion.org/liquid-metal-fusion-reactors/
I'd much rather be a Liquidmetal Wolf than a Liquidmetal Sheep.
Liquidmetal does 🤪
I know there are harebrained ideas there but the point is there has been no press release from LQMT for the Movano rings.
Your Spidey senses should be tingling because something is wrong.
I’ve seen references (couldn’t find them if my life depended on it) of using 3D printed amorphous metals at the academic level. They incorporated Electron Beam (EB) technology to fuse the particles. I would question whether the fusion process destroys the amorphous structure as it crystallizes upon cooling.
Interesting list, some perhaps far fetched but good for discussion…..Lean toward a low royalty/licensing fee since I’ve already estimated the transfer price to Movano at $25-35 per ring and an appropriate royalty usually runs 3-6%. There is also an opportunity for some sort of “kickback” from Eontec/Yihou but don’t hold your breath.
If it helps why not. At this point I would buy a Liquidmetal slinky that keeps on walking for 2 minutes like the bouncing ball after it reaches the last step.
Millions of children intrigued equals high volume and marketing exposure.
What about using 3D printing to create the molds for lqmt injection. This would allow for some very intricate parts
In all of LQMT’s 76 page design guide and in there discussion on comparing LQMT’s Technology to other technologies in manufacturing parts nowhere is amorphous metal 3D printing discussed. Nor do I see it in LQMT’s filed forms as an endeavor they pursued.
Not being an Engineer in this field and from comments read. The formula might have to be altered for a new patent. Also some have claimed 3D amorphous metal printing is not as strong as the process LQMT now uses.
LQMT itself states there are many reasons for using all of the current technologies available to manufacture a particular part.
This might give you a better idea of what LQMT is focused on….
https://www.liquidmetal.com/process-comparison
The design guide is more detailed.
On the other hand since LQMT is a contract company, they can negotiate a fee for a contract with a partner that does use 3D printing using the partners IP. It may not be profitable or advantageous to promote the IP of a potential competitor.
Not being a metallurgist it doesn’t answer your question. But I hope it helps.
Wow, could you add an all of the above choice.
My difficulty is with the $$$ reported in the 4th quarter of around $127,000. I also cannot determine if that figure was based on 4000 rings or 12000 rings. But if and when Movano gets their act together we will always be guessing.
If it ever becomes a much larger $$$ number as part of a deal. I don’t think the terms will matter much. From what TC stated during the CC in terms of any and all contracts he was definitely not talking about millions in contracts this year. Just maybe breaking even.
I believe that’s the low bar set for the year. Imo, if he can’t reach down to meet that level. I see zero reason for anyone in the future to believe anything else he conjures up.
It’s why I mentioned in earlier posts the early twentieth century game of Kick the Can. To give other investors more insight of truly what has been going on, while executives spin there way year after year.
LQMT had a great opportunity to put together a great team of amorphous metal pioneers and blew it with Kang, imo.
If anyone thinks LQMT is with Apple, its because LQMT right now is hanging out on a limb and on this limb that LQMT is hanging out on there are no fruit.
Good luck to you.
Skeptical opinions why LQMT has not made a press release for the Evie Ring (pick only one):
--The deal really is not with LQMT, it's with Eontec or Yihao.
--LQMTs end of the deal is for licensing and the amount is low. So low that management feels the value of additional treasury shares that might be sold by keeping it sorta shadowy will be of greater income than an official press release detailing that the LQMT fee per ring is...I dunno...a buck.
--TC has taken some pointers from Otis Buchannon on how to be an invisible shareholder relations person.
--Lugee Li can not be found. Even just to DHL some SEC compliancy paperwork for him to sign.
--The contract is with Eontec and might not have all the details as if it were done in the USA. Liquidmetal is just a catchy word used for branding.
--Movano is a sketchy company to begin with and they have a whole bunch of complicating issues.
--There is great fear of reprisal by Apple if they get vocal about all of this.
--Even management is confused whether this is a medical instrument or an electronic device. Unclear how to dance around the obvious, it's just plain easier to not write a press release at all and go back to taking a nap.
So many good choices....
Be honest? You get that from Lugee too!
It’s often said who the heck is selling? And of course those who hold shares in LQMT and have a belief in a possible positive outcome, (myself included,) often wonder why? Not that I would blame them given the history.
What I cannot understand given the same history is: Who the heck is buying. I would think, when LQMT hit the 0.03’s, that was a great time to buy.
But now! Who the heck is buying and why so few shares? Makes zero cents to me. One would think at today’s prices you could start a starting position of 250,000 shares with $15K or a 500,000 share position with $30K at .06 cents, no questions asked.
But this dribble just boggles my pea brain.
“I try to present a balanced view based on the facts not on the emotions of anyone hyping or bashing LQMT. I believe I nailed it correctly. This board has had it correct past and present from potential to expectations to hope to FOMO.”
I appreciate you saying this, but I don’t think it’s true that you keep your emotions out of your posts and only stick to facts.
It’s ok, but let’s be honest about our own posts.
I know, it would be asking too much Heaven forbid.
Imagine transparency, accountability and integrity.
No way.
Yeah sure thing Researchify, next thing ya' know you'll be wanting LQMT to acknowledging what ever the Evie Ring deal is ( or...is not) with a press release.
How about shareholder integrity with the 10Q1.
Like updating shareholders as to when the new accounting firm can review the same data through software. It’s not rocket science.
Good luck to all in LQMT.
Wish TC luck.
“Houston, We've Had a Problem.”
Jack Swigert Apollo 13.
My partner has one. It took so long to arrive they gave us a refund so it’s essentially a free ring. Ordered Nov 23 arrived late April 24. She likes it! Sometimes it records her as "sleeping" when she was just sitting up in bed reading. It also records more steps than Apple devices (phone and watch). The app graphics oddly cut off on the side of the phone screen. The app isn’t super intuitive to navigate. All of that said, she likes it. She has the silver color and it’s beautiful. She doesn’t take it off to work in the yard and it hasn’t scratched or anything beyond the most superficial and tiny scuffs that any ring of any metal will get. Nothing deep or alarming. The polish is attractive. Bottom line she thinks it’s a great rev 1, intends to wear it indefinitely, recommends it to others, and enjoys the experience. Plus no monthly fee. Would have been worth the original price in our eyes. (But definitely nowhere near as refined a Oura, not yet.)
Thanks, and many roentgens to ya!
Back in February we had a member of our group purportedly receive an Evie Ring, I'm still wondering about their impressions.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173944883
O.T. For anyone here in Movano….
Who may have missed it on May 6,2024:
Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024
Perhaps a little more light might shine.
Another week passes and LQMT’s share price is down 3% from 0.0615 cents to 0.0596 cents on extremely weak trading volumes and little interest. The same when LQMT moves up or down.
LQMT released 2 8K’s this week as noted and posted by two posters on this board, fricassee & LQMT_Monster. One regarding the dismissal of LQMT’s existing accounting firm and the other hiring a new one. Does the former firm have to compensate LQMT? Will there be any legal action. I guess the way the things are going, I’m almost certain we will learn anything new from posters first and LQMT second. The same way we learned about Zyris and the Ring.
It’s a very sad state of affairs, when LQMT executives can’t update shareholders on the website blog as to what’s going on. Crap that has nothing to do with NDA’s or anything else that requires silence. Just a bunch of lazy arse executives imo, not keeping shareholders up to date on what is going on.
LQMT is now into its 28th consecutive month without a new contract announcement for the order of parts.
Share price is holding in the low pennies. In the upper 0.05’s and lower 0.06’s right now. The walk back down is usually slow after a run up.
As stated a gazillion times: with anemic trading volumes the share price means BUBKIS!
Perhaps in 2025 or 2026 LQMT might succeed and if they ever do make it in 2024, all in it will be very thankful and glad that they did.
FOMO lives and is probably the main reason why anyone holds on regardless of any other opinion at this time. Not wanting to take a loss at this point may be another.
I try to present a balanced view based on the facts not on the emotions of anyone hyping or bashing LQMT. I believe I nailed it correctly. This board has had it correct past and present from potential to expectations to hope to FOMO.
Unfortunately LQMT can still hit the 02’s. Not my wish. The performance of LQMT will decide that.
No matter what anyone’s views are for LQMT going forward. The fundamentals have not changed.
There is potential for a contract announcement to correct the southerly direction LQMT has been heading for the past seven years. If anyone is looking to earn some lunch money, this year could be the time to be in LQMT.
There doesn’t seem to be much enthusiasm for the upcoming 10Q1 whenever that happens. One would think the former accountants completed the 10Q1 before they got canned.
There is also the cloud surrounding the ring and LQMT. Perhaps either company might be able to break through those clouds with a little sunshine.
Would be nice to see an announcement for a high volume reoccurring order again. Could send LQMT up. Way up depending on the contract terms. I hope whatever the contract terms are, they will be better than the ones LQMT usually settles for.
My bet is on one present and one former executive who hold at least 1 million shares and I’m not talking about LL, regardless of how low the SP goes.
Will this be the year revenues increase consistently? Only the 2nd, 3D, and 4th Q’s will tell. I’ll be pleasantly surprised if the 1st Q tics up.
Good luck to all in LQMT.
Wish TC luck.
CEO, Tony Chung, painted a rosy picture for LQMT this year during his CC, for all in LQMT. Especially for outside shareholders, I hope his picture this time, is worth more than just a thousand words to make our shares worth more than just three, four, five or six cents. So far his artwork wasn’t worth much more than that last year.
They said they had triple the demand then what was sold. So I don’t know exactly if they are waiting for fda approval other than to iron out existing issues which was mainly $$$ to fulfill orders for manufacturing. I think they admitted that the demand exceeded there expectations.
I hope their relaunch is successful. It would be a big help for marketing with FDA approval. They now have the resources to meet greater demand.
They have a very qualified team to make it a success. Any success using LQMT’s IP and process from LL abroad should benefit the shareholders of LQMT.
Basing what LQMT reported during 10Q4 see the 10K, LQMT could see revenues increase $300,000 to $1 million plus this year from ring sales. The potential for LQMT to rise on increasing ring sales should be enough to raise the pps above a dime if the sales take place.
I heard they’re planning to "relaunch" this summer or fall, probably after FDA approval.
The left arm being closer to the heart generally gives a higher reading than the right arm. Never do a second reading on the same arm immediately as arteries have been constricted a little and will give you a false reading. Wait 10 minutes. In the meantime one can immediately take another reading on the opposite arm.
“You didn’t mention glucose monitoring and whether the timing is sooner or later than BP. “
I didn’t have to. They are not doing it. They are looking into a wristband for both BP and glucose. Their attempt at adding BP to the ring are years away for trials and FDA approval.
The focus on their success right now depends on women and FDA approval to increase demand. If their apps are too difficult to function and also still limited to iOS, then they have more kinks to iron out. It’s a start up company. The way things work out is when they start getting real feed back from the women who are now wearing the ring.
In essence the real trial has just begun and it takes about three months of data to get a better understanding to use the ring for the purpose it was sold.
I do not own any stock in movano.
If you have any doubts about what I posted, feel free to contact them. I may have misunderstood some of the comments made by the executives at movano regarding their business plans for the future. EOS.
I agree with you and Chip, there is not much there to look at, so who cares.. Certainly I have no information to change that. On the other hand, as far as I know, LQMT does not have an internal auditor on the payroll. so I do not know how that functions, which makes the external audit even more useful. It is more than just adding and subtracting, it is verifying the basis.. For example, some folks here wondered where the debt securities for their services.were held, and who issued them? An audit would verify their existence. Borges apparently missed a few steps along the way for their clients. Not a good look. I wonder if they were usually low bid? Anyway, steps were taken to remedy the situation.
That is a good post Research ..... and hopefully a big part of the equation is that LQMT had to select somebody fairly quickly ...... and since M&K has been under incredible scrutiny ... maybe this is a good thing ... and again I feel as long as LQMT does not start blowing a lot of smoke and BS, then most everything else has been fairly normal for pioneering innovations of such a huge magnitude....
I believe the accountants for LQMT followed the rules for LQMT. Now there probably are a few accountants that may have made errors innocently or not. Could be political for all I know and they didn’t do anything wrong or it could be something else. But LQMT’s data on the 10K seems to be clear. You know the saying even if they were to put lipstick on a pig, it would still be a pig. I would venture to say that the 10Q1 would have been the same. Either they break the low bar of $30 thousand in revenue or they don’t. It’s not a big deal.
A big deal would be LQMT and their rag tag sales force to announce contracts, orders real growth.
That is the focus.
It would make zero sense to delay a $0.00 10Q1 or a $300 thousand dollar 10Q1. Neither would raise the sp to where investors want it to go.
Yes it would be great for my short term 2 years plus wash rinse and repeat cycle investment. But not for my long term position in LQMT. And that includes anyone else who bought a position for short term gains.
If LQMT continues without a deal, those short term positions will be like having another long term position.
Good luck to you.
BP monitoring can be very difficult….I can’t get my right arm to duplicate my left. At the doctor’s office, I sit in a straight backed chair, uncross my legs, keep the measuring device at roughly the level of my heart and refrain from talking….by the way DON’T MOVE.
If that protocol is the baseline and one expects to get a reliable reading from a person who is going about daily activities, I’ll bet getting into the FDA guidelines/expectations is a huge hurdle. You almost have to take multiple (>10) readings and do some pretty sophisticated smoothing. Erratic readings need to be dealt with…maybe an average with some indication of confidence limits.
If a person has orthostatic hypotension, the act of standing up can cause their systolic BP to drop 20mm and recover in a few seconds….big challenge.
I don’t recall the BP monitoring being years away…I expect the hitch may be continuously monitoring instead of BP on demand or BP every 30 minutes…lots of options. You didn’t mention glucose monitoring and whether the timing is sooner or later than BP. Some of the same issues on frequency…you don’t really need continuous monitoring but the interval and trend tracking needs to be ironed out.
I don’t think there was very much “wiggle room” to play fast and loose with LQMT……they certainly didn’t inflate revenues or net income and the rest is cash and rental income. Pretty cut and dry.
Not saying. Just adding FYI…
https://www.sec.gov/files/litigation/admin/2015/33-9918.pdf
https://www.sec.gov/files/litigation/apdocuments/3-16339-event-42.pdf
https://pcaobus.org/Inspections/Reports/Documents/104-2018-083-MK-CPAS.PDF
https://assets.pcaobus.org/pcaob-dev/docs/default-source/inspections/reports/documents/104-2024-021-m-k.pdf?sfvrsn=24c0079a_4
https://bestcpafirmshouston.com/
The last link is strictly for Houston TX,
As far as I know and I know very little the firm is qualified.
Another great post.
Absolutely correct…
https://www.prnewswire.com/news-releases/movano-health-submits-exemplary-sp02-clinical-trial-results-in-key-step-towards-fda-510k-clearance-decision-302140861.html
The sp02 imo, is not a big deal. Blood pressure would be, as it would capture every one’s interest from any gender. The blood oxygen is a big deal for anyone with a pulmonary issue or contracting flu like symptoms. During a pandemic it would be a serious helpful aid.
Other than people who have pulmonary issues with blood oxygen saturation, I don’t think right now is the reason to go out and buy this product.
The blood pressure measurement would be huge. According to MOVANO, they are years away from that achievement. Presently I can see the application being successful for women if the data is accurate.
I’m sure your comments come from personal experience and movano’s own admission of not being ready to roll out much larger demand. Looks like they have the resources to get their act together long term. But as for now their stock price is in the crapper.
I think that logic is being reflected in the trading.
1500 incidents. Makes one wonder what they have been doing for LL and the gang.
I completely disagree that Research posts are annoying. They are what LQMT has led them to be. I don’t even view them as pessimistic. Just factual. I’m a long term holder as well. But let’s be real here people. They really don’t do much of anything. But there is potential for them to or we all would t be here.
Followers
|
885
|
Posters
|
|
Posts (Today)
|
4
|
Posts (Total)
|
233418
|
Created
|
04/30/05
|
Type
|
Free
|
Moderators PatentGuy1 Almosthere |
Liquidmetal® Technologies (ISO 9001:2008 certified) is a leading force in the research, development and commercialization of amorphous metals. Our revolutionary class of patented alloys and processes form the basis of high performance materials in a broad range of medical, military, consumer, industrial, and sporting goods products.
Discovered by researchers at the California Institute of Technology, Liquidmetal alloys’ unique atomic structure enables applications to achieve performance and accuracy levels that have not been possible before. The revolutionary class of patented materials technology redefine performance and design paradigms institutionalized by traditional materials.
As Liquidmetal Technologies controls the intellectual property rights with more than 70 U.S. patents, these high performance materials are dramatically changing the way companies develop new products.
LINKS
Featured: Automotive Pressure Sensors, 9.36 billion market by 2020
1. LiquidMetal Website
2. LiquidMetal Manufacturing Facility
3. OTC Market Report
4. Engel Liquidmetal Forum (Nov 2015)
5. ENGEL Symposium 2015
6. ENGEL Interview on Liquidmetal
PATENTS (USPTO)
1. Search Crucible Intellectual (Apple and LiquidMetal R&D)
2. Search Apple and LiquidMetal
3. Search Cross-license Patents w/Eontec
4. Search Vitreloy
5. Search Pre-grant Patents
VIDEOS
1. OMEGA Liquidmetal Bezel
2. ENGEL e-motion 110T
3. Liquidmetal Bouncing Ball
CORPORATE GOVERNANCE - BOARD OF DIRECTORS
Professor Lugee Li, Chairman
Professor Li was appointed as a member of our board of directors in March 2016 and became Chairman of our board of directors in October 2016. Professor Li is the founder, Chairman, and majority stockholder of DongGuan Eontec Co. Ltd., a Hong Kong company listed on the Shenzen Stock Exchange engaged in the production of precision die-cast products and the research and development of new materials. Professor Li founded Eontec in 1993 and has served as Chairman since that date. At Eontec, Professor Li is responsible for strategic development and research and development. Professor Li is also the founder and sole shareholder of Leader Biomedical Limited, a Hong Kong company engaged in the supply of biomaterials and surgical implants. Professor Li serves as an analyst for the Institute of Metal Research at the Chinese Academy of Sciences and serves part-time as a professor at several universities in China.
Abdi Mahamedi, Vice Chairman
Abdi Mahamedi has served on our board of directors since May 2009 and became Vice-Chairman of our board of directors in October 2016. Since 1987, Mr. Mahamedi has served as the President and Chief Executive Officer of Carlyle Development Group of Companies (“CDG”), which develops and manages residential and commercial properties in the United States on behalf of investors worldwide. At CDG, Mr. Mahamedi evaluates and supervises all of the investment activities and management personnel. Prior to joining CDG, Mr. Mahamedi founded Emanuel Land Company, a subsidiary of Emanuel & Company, a Wall Street investment banking firm, and served as a managing director for Emanuel Land Company from 1986 to 1987. In 1983, Mr. Mahamedi received his B.S.E. degree in Civil and Structural Engineering from the University of Pennsylvania, and in 1984 he received his M.S.E. degree in Civil and Structural Engineering from the University of Pennsylvania.
Isaac Bresnick
Currently serves as Legal and Regulatory Affairs Director for the Leader Biomedical Group, a private company based in Hong Kong and operating from Amsterdam, the Netherlands, and has served in that role since October 2014. At Leader Biomedical, Mr. Bresnick is responsible for the direction and management of legal affairs, regulatory affairs, quality control, and quality assurance, as well as for advising executive management of Group companies. Mr. Bresnick also currently serves as Director of AAP Joints GmbH, a private company in Berlin, Germany, and has served in that role since July 2013. Mr. Bresnick received his J.D. from the University of Connecticut School of Law in 2013, and his B.S. in Industrial Design from the University of Bridgeport in 2008. After completion of his undergraduate studies and continuing through his enrollment at UCONN Law, Mr. Bresnick worked as Senior Arrangements Designer for Electric Boat Corporation, a subsidiary of General Dynamics, from June 2008 to December 2012.
Vincent Carrubba
An experienced corporate leader and serial entrepreneur with extensive senior executive, technical and manufacturing experience. Mr. Carrubba has created and guided new products to success in the consumer goods, electronics, automotive and construction industries and has conceptualized, financed and built factories and developed new manufacturing technologies throughout Asia. From September 2014 through the present, Mr. Carrubba has served as the CEO of Admiral Composite Technologies Inc. (“Admiral”), where he has developed new technologies for environmentally responsible and innovative building materials which represent Admiral’s product lines. Mr. Carrubba has also served as Admiral’s Chairman since its inception in 2009. From September 2014 through the present, Mr. Carrubba has served as the CEO of Asia Sourcing & Communications USA Inc. and he has served as its Chairman since its inception in 2013. From 2002 through August 2014, Mr. Carrubba served as the Director of R&D for Interdynamics Inc., IDQ Holdings, where he was responsible for all R&D and QC matters, including the management of engineering, legal, patenting, regulatory, insurance and consumer relations matters. From 1989 through 1992, Mr. Carrubba designed and installed the New York Stock Exchange telecommunications and information technology systems. Mr. Carrubba has held engineering and executive positions with Xerox, General Electric, Bristol-Meyers Squibb and AT&T and he is the inventor of several patents related to telecommunications, professional tools and consumer products. Mr. Carrubba received a Bachelor of Arts degree in Engineering Science and a Bachelor of Science Degree in Mechanical Engineering from Columbia University SEAS in 1982.
Tony Chung
Mr. Chung was appointed to our board of directors in August 2017. Mr. Chung had previously served as the Company’s Chief Financial Officer from December 2008. Prior to joining the Company, Mr. Chung served as CFO at BETEK Corporation, a real estate and investment subsidiary of SK Engineering and Construction, and as CFO of Solarcity, a company providing advanced solar technology and installation services. Mr. Chung is a Certified Public Accountant and served eight years at KPMG as an Audit and Consulting Manager for several large multinational companies. He received his B.S. degree in Business Administration from the University of California, Berkeley. Mr. Chung is also an Attorney at Law and received his J.D. degree from Pacific Coast University School of Law.
Reporting Status | U.S. Reporting: SEC Reporting |
Audited Financials | Audited |
Latest Report | August 4, 2020 10Q |
CIK | 0001141240 |
Fiscal Year End | 12/31 |
OTC Marketplace | OTCQB |
Market Value1 | $129,851,894 | a/o Sep 24, 2020 | |
Authorized Shares | 1,100,000,000 | a/o Dec 31, 2016 | |
Outstanding Shares | 914,449,957 | a/o Sep 24, 2020 | |
-Restricted | Not Available | ||
-Unrestricted | Not Available | ||
Held at DTC | Not Available | ||
Float | 487,690,350 | a/o Dec 31, 2017 | |
Par Value | No Par Value |
Shareholders of Record | 217 | a/o Dec 31, 2017 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |